New US And Singapore Labs Will Improve Healthcare Efficiency

Published
03 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
€2.90
19.1% undervalued intrinsic discount
15 Aug
€2.35
Loading
1Y
-24.8%
7D
-1.1%

Author's Valuation

€2.9

19.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 0.69%

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 0.69%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.